Chairman of the board
Ofer Haviv holds the position of Evogene’s President and CEO as of late 2004. During his time at Evogene, he led two IPOs, in the Tel Aviv stock exchange (2008) and NYSE (2013). Additionally, during these years, Evogene had initiated several multi-year collaborations with world leading companies such as: Monsanto, BASF, Bayer, Corteva, Syngenta and ICL, to name a few.
Dr. Arnon Heyman
Dr. Arnon Heyman is the CEO of Canonic Ltd. Dr. Heyman has previously served as VP and GM of Evogene's Ag-Seeds division managing all plant genetics activities and related collaborations. Prior to Evogene, Dr. Heyman served as CTO of BondX Technologies Ltd. from 2009-2014.
Dr. Heyman holds a PhD. In Biotechnology from the Hebrew University in Jerusalem (2008) and a MBA from the College of Management (2015).
Dr. Inbal Dangoor
Dr. Inbal Dangoor is an experienced plant scientist with expertise in genetics, biotechnology and computational biology. Prior to joining Canonic, Dr. Dangoor managed the New Breeding Technologies activities of Evogene and was the Corn research team leader in the Yield and Abiotic Stress division.
Dr. Dangoor holds a Ph.D. from the Weizmann Institute of Science in Rehovot (2010).